Allelotype of uterine leiomyomas

Cancer Genetics and Cytogenetics

Volumn 114, Issue 2, 1999, Pages 89-95

  Mao, Xin ^a   Barfoot, Rita ^a   Hamoudi, Rifat A ^a   Easton, Douglas F ^b   Flanagan, Adrienne M ^c   Stratton, Michael R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA MINISATELLITE;

ALLOTYPE; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CHROMOSOME 7Q; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; DISEASE PREDISPOSITION; FEMALE; GENE AMPLIFICATION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MULTIPLE CANCER; PRIORITY JOURNAL; UTERUS MYOMA;

ALLELES; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LEIOMYOMA; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; UTERINE NEOPLASMS;

EID: 0032856432     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00053-9     Document Type: Article

References (36)

1. Whitfield C.R. Dewhurst's Textbook of Obstetrics and Gynecology for Post-Graduates. 4th ed:1986;726-733 Blackwell Scientific Publications, London.
2. Clark-Pearson D.L., Dawood M.Y. Green's Gynecology. Essentials of Clinical Practice:1990;Little Brown, and Co, Boston.
3. Baird D.T., Bramley T.A., Hawkins T.A., Lumsden M.A., West C.P. Effect of treatment with LHRH analogue Zoladex on binding of oestradiol, progesterone and epidermal growth factor to uterine fibromyomata. Horm Res. 32:1989;154-156.
4. Vanni R., Lecca U., Faa G. Uterine leiomyoma cytogenetics II. Report of forty cases. Cancer Genet Cytogenet. 53:1991;247-256.
5. Pandis N., Heim S., Bardi G., Floderus U.M., Willen H., Mandahl N., Mitelman F. Chromosome analysis of 96 uterine leiomyomas. Cancer Genet Cytogenet. 55:1991;11-18.
6. Ozisik Y.Y., Meloni A.M., Surti U., Sandberg A.A. Deletion of 7q22 in uterine leiomyomas. A cytogenetic review. Cancer Genet Cytogenet. 71:1993;1-6.
7. Han K., Lee W., Harris C.P., Simsiman R.C., Lee K., Kang C., Meisner L.F. Comparison of chromosome aberrations in leiomyoma and leiomyosarcoma using FISH on archival tissues. Cancer Genet Cytogenet. 74:1994;19-24.
8. Sargent M.S., Weremowicz S., Rein M.S., Morton C.C. Translocations in 7q22 define a critical region in uterine leiomyomata. Cancer Genet Cytogenet. 77:1994;65-68.
9. Dal Cin P., Moerman P., Deprest J., Brosens I., Van den Berghe H. A new cytogenetic subgroup in uterine leiomyoma is characterized by a deletion of the long arm of chromosome 3. Genes Chromosom Cancer. 13:1995;219-220.
10. Henning Y., Rogalla P., Wanschura S., Frey G., Deichert U., Bartnitzke S., Bullerdiek J. HMGIC expressed in a uterine leiomyoma with a deletion of the long arm of chromosome 7 along with a 12q14-15 rearrangement but not in tumors showing del(7) as the sole cytogenetic abnormality. Cancer Genet Cytogenet. 96:1997;129-133.
11. Fletcher J.A. Cytogenetic markers in selected gynecological malignancies. Wolman S.R., Sell S. Human Cytogenetic Cancer Markers. 1997;169-202 Humana Press, Totowa.
12. Vanni R., Marras S., Schoenmakers E.F.P.M., Dal Cin P., Kazmeierczak B., Senger G., Bullerdiek J., van de Ven W.J.M., Van den Berghe H. Molecular cytogenetic characterization of del(7q) in two uterine leiomyoma-derived cell lines. Genes Chromosom Cancer. 18:1997;155-161.
13. Ishwad C.S., Ferrell R.E., Davare J., Meloni A.M., Sandberg A.A., Surti U. Molecular and cytogenetic analysis of chromosome 7 in uterine leiomyomas. Genes Chromosom Cancer. 14:1995;51-55.
14. Ishwad C.S., Ferrell R.E., Hanley K., Davare J., Meloni A.M., Sandberg A.A., Surti U. Two discrete regions of deletion at 7q in uterine leiomyomas. Genes Chromosom Cancer. 19:1997;156-160.
15. Sell S.M., Altungoz O., Prowse A.A., Meloni A.M., Surti U., Sandberg A.A. Molecular analysis of chromosome 7q21.3 in uterine leiomyoma. analysis using markers with linkage to insulin resistance Cancer Genet Cytogenet. 100:1998;165-168.
16. Mashal R.D., Fejzo M.L., Friedman A.J., Mitchner N., Nowak R.A., Rein M.S., Morton C.C., Sklar J. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosom Cancer. 11:1994;1-6.
17. Xing Y.P., Powell W.L., Morton C.C. The del(7q) subgroup in uterine leiomyomata. genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata Cancer Genet Cytogenet. 98:1997;69-74.
18. Packenham J.P., du Manoir S., Schrock E., Risinger J.I., Dixon D., Denz D.N., Evans J.A., Berchuck A., Barrett J.C., Devereux T.R., Ried T. Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization. Mol Carcinog. 19:1997;273-279.
19. Sandberg A.A., Bridge J. The Cytogenetics of Bone and Soft Tissue Tumors. 1994;R. Landes Company, Austin.
20. Vikhlyaeva E.M., Khodzhaeva Z.S., Fantschenko N.D. Familial predisposition to uterine leiomyomas. Int J Gynaecol Obstet. 51:1995;127-131.
21. Neuhausen S.L., Marshall C.J. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res. 54:1994;6069-6072.
22. Collins N., McManus R., Wooster R., Mangion J., Seal S., Lakhani S.R., Ormiston W., Daly P.A., Ford D., Easton D.F., Stratton M.R. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene. 10:1995;1673-1675.
23. Biggs P.J., Wooster R., Ford D., Chapman P., Mangion J., Quirk Y., Easton D.F., Burn J., Stratton M.R. Familial cylindromatosis (turban tumor syndrome) gene localised to chromosome 16q12-q13. evidence for its role as a tumor suppressor gene Nature Genet. 11:1995;441-443.
24. Biggs P.J., Chapman P., Lakhani S.R., Burn J., Stratton M.R. The cylindromatosis gene (cyld1) on chromosome 16q may be the only tumor suppressor gene involved in the development of cylindromas. Oncogene. 12:1996;1375-1377.
25. Hemminki A., Tomlinson I., Markie D., Jarvinen H., Sistonen P., Bjorkqvist A.M., Knuutila S., Salovaara R., Bodmer W., Shibata D., de la Chapelle A., Aaltonen L.A. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nature Genet. 15:1997;87-90.
26. Gyapay G., Morissette J., Vignal A., Dib C., Fizames C., Millasseau P., Marc S., Bernardi G., Lathrop M., Weissenbach J. The 1993-94 Genethon human genetic linkage map. Nature Genet. 7:1994;246-339.
27. Chumakov I.M., Rigault P., Le Gall I., Bellanne Chantelot C., Billault A., Guillou S., Soularue P., Guasconi G., Poullier E., Gros I., Belova M., Sambucy J.L., Susini L., Gervy P., Glibert F., Beaufils S., Bui H., Massart C., Detand M.F., Dukasz F., Lecoulant S., Ougen P., Perrot V., Saumler M., Soravito C., Bahouayila R., Cohenakenine A., Barillot E., Bertrand S., Codani J.I., Caterina D., Georges I., Lacroix B., Lucotte G., Sahbatou M., Schmit C., Sangouard M., Tubacher E., Dib C., Faure S., Fizames C., Gyapay G., Millasseau P., Nguyen S., Muselet D., Vignal A., Morissette J., Menninger J., Lieman J., Desai T., Banks A., Brayward P., Ward D., Hudson T., Gerety S., Foote S., Stein L., Page D.C., Lander E.S., Weissenbach J., Lepaslier D., Cohen D. A YAC contig map of the human genome. Nature. 377:1995;175-298.
28. Naylor S.L., Carritt B., Boileau C., Beroud C., Alexander C., Allderdice P., Alimov A., Ashworth T., Bonifas J., Bugert P., Buys C.H.C.M., Chipperfield M.A., Deng H., Drabkin H., Gemmill R.M., Grompe M., Joensuu T., Jonasdottir A., Gizatullin R., Krols L., Leach R.J., Lott S.T., Killary A., Martinsson T., Messiaen L., O'Connell P., Opalka B., Plaetke R., Sankila E.M., Smith D.I., Strachen T., van den Berg A., Zabarovsky E. Report of the sixth international workshop on human chromosome 3 mapping 1995. Cytogenet Cell Genet. 72:1996;255-270.
29. Marynen P., Kucherlapati R. Report of the third international workshop on human chromosome 12 mapping 1995. Cytogenet Cell Genet. 73:1996;1-24.
30. Shimizu N., Antonarakis S.E., Van Broeckhoven C., Patterson D., Gardiner K., Nizetic D., Creau N., Delabar J.M., Korenberg J., Reeves R., Doering J., Chakravati A., Minoshima S., Ritter O., Cuticchia J. Report of the fifth international workshop on human chromosome 21 mapping 1994. Cytogenet Cell Genet. 70:1995;147-182.
31. Scambler P.J. Report of the fourth international workshop on human chromosome 22 mapping 1994. Cytogenet Cell Genet. 67:1994;278-294.
32. Zenklusen J.C., Thompson J.C., Troncoso P., Kagan J., Conti C.J. Loss of heterozygosity in human primary prostate carcinomas. a possible tumor suppressor gene at 7q31.1 Cancer Res. 54:1994;6370-6373. a.
33. Zenklusen J.C., Bieche I., Lidereau R., Conti C.J. C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci USA. 91:1994;12155-12158. b.
34. Zenklusen J.C., Thompson J.C., Klein-Szanto A.J., Conti C.J. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1. evidence for a broad range tumor suppressor gene Cancer Res. 55:1995;1347-1350. a.
35. Zenklusen J.C., Weitzel J.N., Ball H.G., Conti C.J. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene. Oncogene. 11:1995;359-363. b.
36. Koike M., Takeuchi S., Yokota J., Park S., Hatta Y., Miller C.W., Tsuruoka N., Koeffler H.P. Frequent loss of heterozygosity in the region of the D7S523 locus in advanced ovarian cancer. Genes Chromosom Cancer. 19:1997;1-5.